Clinical Trial Update: The Study of [14C] GZR18 [Phase 1]

View source ↗

Summary

A Phase 1 study of the radiolabeled compound [14C] GZR18 in overweight/obese individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• [14C] GZR18 (GZR18)

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Overweight, Obese | Phase 1 | Status: COMPLETED